Close

Kitov Pharma (KTOV) Reports Consensi Commercialization Agreement for China

May 11, 2018 8:34 AM EDT Send to a Friend
Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the Company has signed a definitive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login